Heart Failure Seminar: Focus on HFSA Scientific Statement on Cardio-Oncology and Heart Failure
April 8, 2025 | 5:00 PM - 6:30 PM ET | Virtual Livestream; OnDemand to follow
Join us on April 8 at 5:00 PM ET for the HFSA Heart Failure Seminar: Focus on HFSA Scientific Statement on Cardio-Oncology and Heart Failure – A Focus on Key Takeaways. This dynamic, case-based virtual seminar will explore the Cardio-Oncology and Heart Failure Scientific Statement from the Heart Failure Society of America. Hear directly from the statement's authors as they discuss four complex case presentations, followed by insightful panel discussions.
This seminar is now available OnDemand for purchase in the HFSA Learning Center.
About the HFSA Scientific Statement: Cardio-Oncology and Heart Failure
Released in October 2024, the statement revealed a critical connection between heart failure (HF) and cancer, with shared mechanisms contributing to the incidence and progression of both diseases. Cardio-Oncology and Heart Failure: A Scientific Statement from the Heart Failure Society of America, published in the Journal of Cardiac Failure (JCF), shows that patients with cancer are at increased risk of developing HF, while HF patients face a higher risk of cancer, emphasizing the need for coordinated care between cardiology and oncology.
Read the full statement
Read a press release with more information
The HFSA Heart Failure Seminar: Focus on HFSA Scientific Statement on Cardio-Oncology and Heart Failure is part of the HFSA’s ongoing Focus On seminar series which brings together healthcare providers (HCPs) on key topics.